Μάι152024ΝέαFeaturedΑνακοινώσειςΛοιπές Εκδηλώσεις Τετάρτη 15/5/2024 και ώρα 18.00 Κάνετε ΕΔΩ την εγγραφή σας Κατηγορίες Νέα, Featured, Ανακοινώσεις, Λοιπές Εκδηλώσεις15 Μαΐου 2024 Μοιραστείτε το! Share on FacebookShare on Facebook Share on XShare on X Share on LinkedInShare on LinkedIn Share on WhatsAppShare on WhatsApp Post navigationΠροηγούμενοPrevious post:Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label TrialΕπόμενοNext post:Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosisΣχετικά ΆρθραImpact of first and further decompensation in patients with compensated ACLD due to MASLD23 Ιανουαρίου 2026Anti-HBs immune complex levels: A novel marker of hepatitis flare following nucleos(t)ide analogue withdrawal in HBeAg-negative chronic hepatitis B21 Ιανουαρίου 2026Establishing hepatic decompensation as a meaningful clinical outcome during systemic therapy for hepatocellular carcinoma19 Ιανουαρίου 2026The relationship between mean arterial pressure and terlipressin in hepatorenal syndrome-acute kidney injury reversal: A post hoc analysis14 Ιανουαρίου 20265o Webinar ΕΕΜΗ “MASLD: Συζήτηση Περιπτώσεων”17 Δεκεμβρίου 2025The burden of extrahepatic organ failures in European patients with cirrhosis15 Δεκεμβρίου 2025
Impact of first and further decompensation in patients with compensated ACLD due to MASLD23 Ιανουαρίου 2026
Anti-HBs immune complex levels: A novel marker of hepatitis flare following nucleos(t)ide analogue withdrawal in HBeAg-negative chronic hepatitis B21 Ιανουαρίου 2026
Establishing hepatic decompensation as a meaningful clinical outcome during systemic therapy for hepatocellular carcinoma19 Ιανουαρίου 2026
The relationship between mean arterial pressure and terlipressin in hepatorenal syndrome-acute kidney injury reversal: A post hoc analysis14 Ιανουαρίου 2026
